Details

Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 26, 2026 · edition #6
Timestamp: 2026-01-26T11:47:13.925Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html
Replay URL: https://replay.healtharchive.ca/job-6/20260126114713/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html#ha_snapshot=415524
ID: 415524
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots